Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-908-3 | CAS number: 19444-21-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Report date:
- 1998
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- prop-2-en-1-yl 2-hydroxy-2-methylpropanoate
- EC Number:
- 700-908-3
- Cas Number:
- 19444-21-4
- Molecular formula:
- C7H12O3
- IUPAC Name:
- prop-2-en-1-yl 2-hydroxy-2-methylpropanoate
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Himalayan
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: BRL Biological Research Laboratories Ltd, 4414 Füllerinsdorf, Switzerland
- Age at study initiation: Young adult (approximately 1-3 month)
- Weight at study initiation: 309 - 439 g
- Housing: Individual
- Diet: ad libitum
- Water : ad libitum from bottles
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3°C
- Humidity (%): 50% ± 20%
- Air changes (per hr): 13-14/hour
- Photoperiod (hrs dark / hrs light): 12/12 hours
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Vehicle:
- peanut oil
- Concentration / amount:
- Induction injection: 5.0%
Epidermal induction: 0.5%
Challengeopen allclose all
- Vehicle:
- peanut oil
- Concentration / amount:
- Induction injection: 5.0%
Epidermal induction: 0.5%
- No. of animals per dose:
- 1
- Details on study design:
- RANGE FINDING TESTS:
Pre-tests, Intradermal Induction
Injections of 0.5, 1.0, 3.0, and 5.0% CA 2215 A in peanut oil produced irritation at the injection site for all concentrations. The 5.0% concentration was selected for the induction injection for the definitive test, in that it was suitable for injection, systematically well tolerated, and produced mild to moderate skin irritation. Individual irritation scores are presented in Table 1.
Pre-test, Epidermal Application
Epidermal application of 0.05, 0.1, 0.3, 0.5, 1, 5, 10, 20, 30, 50, 80 and 100% (undiluted) concentrations produced skin irritation in both animals at 1% and higher. The undiluted (100%) test article was selected for epidermal induction at the highest concentration to produce mild to moderate irritation. The 0.5% concentration was the highest concentration to produce no irritation (highest non-irritant dose), and was therefore selected for the epidermal challenge application. Individual irritation scores are presented in Table 2.
MAIN STUDY:
Day 0 – Intradermal Induction Injections
Concentration and Vehicle, test article: 5.0% in peanut oil
Pre-treatment: An area approximately 5cm x 5cm on the back of the neck was shaved approximately 1 hour before treatment.
Treatment: Three pairs of injections of 0.1ml in volume were given in the shaved area so that one of each pair was
on each side of the midline.
Vehicle control group injections: (1) adjuvant/physiological saline mixture, 1:1 v/v
(2) peanut oil
(3) peanut oil, 50% v/v with 1:1 adjuvant/physiological saline mixture
Test article group injections: (1) adjuvant/physiological saline mixture, 1:1 v/v
(2) CA 2215 A in peanut oil
(3) CA 2215 A in 1:1 adjuvant/physiological saline mixture
Day 8 – Epidermal Application Induction
Concentration and Vehicle, test article: 100 % undiluted
Treatment: A filter paper patch was fully loaded (approximately 0.4g) with undiluted test article (test article group) or peanut oil vehicle alone (vehicle control group) and held in place with the occlusive dressing for 48 hours.
Day 21- Epidermal Application Challenge
Vehicle: peanut oil
Concentration tested, test article: 0.5 % (highest non-irritant dose)
Pre-treatment: The flanks of the animals were shaved immediately prior to treatment.
Treatment: One chamber loaded with the test article/vehicle mixture (approximately 0.35 ml) was placed on one flank (test flank) and one chamber loaded with the vehicle alone was placed on the other flank
(vehicle flank) of the animals of both groups. The chambers were held in place with the occlusive
dressing for 24 hours. - Positive control substance(s):
- no
Results and discussion
Any other information on results incl. tables
Pre-tests, Intradermal Induction
Injections of 0.5, 1.0, 3.0, and 5.0% CA 2215 A in peanut oil produced irritation at the injection site for all concentrations. The 5.0% concentration was selected for the induction injection for the definitive test, in that it was suitable for injection, systematically well tolerated, and produced mild to moderate skin irritation. Individual irritation scores are presented in Table 1.
Pre-test, Epidermal Application
Epidermal application of 0.05, 0.1, 0.3, 0.5, 1, 5, 10, 20, 30, 50, 80 and 100% (undiluted) concentrations produced skin irritation in both animals at 1% and higher. The undiluted (100%) test article was selected for epidermal induction at the highest concentration to produce mild to moderate irritation. The 0.5% concentration was the highest concentration to produce no irritation (highest non-irritant dose), and was therefore selected for the epidermal challenge application. Individual irritation scores are presented in Table 2.
Skin Irritation Check
To document irritation by the test article during epidermal induction, sites were examined 1 hour after removal of the dressing for the epidermal induction. Positive skin irritation reactions were noted for all animals in the CA 2215 A group. There were no positive reactions among the vehicle control group animals. Results are presented in Table 3.
Skin Reactions following Challenge Application
Positive reactions on the test flanks were only observed in one female (no.295) of the test group animals after 24 hour examination. The sensitization rate for CA 2215 A was therefore 5%.
Sensitization reactions are summarized in table 4, and individual animal Draize scores are present in Tables 5 and 6 for vehicle control and CA 2215 A group animals, respectively.
There was no mortality in the test.
There were no remarkable clinical observations.
Body weights were not affected by treatment. Individual body weights are presented in Table 7.
Table 1: Intradermal Induction Pretest, Test Article in peanut oil
Driaze Scores
SEX/ANIMAL# |
AFTER 24 HOURS |
AFTER 48 HOURS |
||||||
M/1 |
F/2 |
M/1 |
F/2 |
M/1 |
F/2 |
M/1 |
F/2 |
|
CONCENTRATION |
ERYTHEMA |
EDEMA |
ERYTHEMA |
EDEMA |
||||
0.5% |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
0 |
1.0% |
1 |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
3.0% |
1 |
1 |
1 |
1 |
2 |
2 |
1 |
1 |
5.0% |
1 |
1 |
1 |
1 |
2 |
2 |
2 |
2 |
Table 2: Epidermal Application Pretest, Test Article in peanut oil
Draize Scores
SEX/ANIMAL# |
AFTER 24 HOURS |
AFTER 48 HOURS |
||||||
M/1 |
F/2 |
M/1 |
F/2 |
M/1 |
F/2 |
M/1 |
F/2 |
|
CONCENTRATION |
ERYTHEMA |
EDEMA |
ERYTHEMA |
EDEMA |
||||
30% |
1 |
1 |
0 |
1 |
1 |
1 |
0 |
1 |
50% |
1 |
1 |
0 |
2 |
1 |
1 |
0 |
2 |
80% |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
100% |
2 |
1 |
2 |
1 |
2 |
2 |
1 |
1 |
SEX/ANIMAL# |
AFTER 24 HOURS |
AFTER 48 HOURS |
||||||
M/3 |
F/4 |
M/3 |
F/4 |
M/3 |
F/4 |
M/3 |
F/4 |
|
CONCENTRATION |
ERYTHEMA |
EDEMA |
ERYTHEMA |
EDEMA |
||||
1% |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
0 |
5% |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
0 |
10% |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
20% |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
1 |
SEX/ANIMAL# |
AFTER 24 HOURS |
AFTER 48 HOURS |
||||||
M/6 |
F/6 |
M/5 |
F/6 |
M/5 |
F/6 |
M/5 |
F/6 |
|
CONCENTRATION |
ERYTHEMA |
EDEMA |
ERYTHEMA |
EDEMA |
||||
0.05% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.1% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.3% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.5% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Note: Different pairs of animals (one male, one female) were used for the two pretests (Tables 1-2)
Table 3: Skin Irritation Check After Epidermal Induction
Day 10, Observations 1 hour after patch removal
VEHICLE CONTROL |
TEST ARTICLE |
||
SEX/ANIMAL# |
REACTION |
SEX/ANIMAL# |
REACTION |
M/271 |
- |
M/276 |
+ |
M/272 |
- |
M/277 |
+ |
M/273 |
- |
M/278 |
+ |
+M/274 |
- |
M/279 |
+ |
+M/275 |
- |
M/280 |
+ |
|
|
M/281 |
+ |
|
|
M/282 |
+ |
|
|
M/283 |
+ |
|
|
M/284 |
+ |
|
|
M/285 |
+ |
|
|
|
|
F/286 |
- |
F/291 |
+ |
F/287 |
- |
F/293 |
+ |
F/288 |
- |
F/293 |
+ |
F/289 |
- |
F/294 |
+ |
F/290 |
- |
F/295 |
+ |
|
|
F/296 |
+ |
|
|
F/297 |
+ |
|
|
F/298 |
+ |
|
|
F/299 |
+ |
|
|
F/300 |
+ |
- = negative + = positive
Table 4: Summary of Positive Skin Reactions after Challenge Application
Number of Animals with Positive Responses/Number of Animals in Group
|
VEHICLE FLANK |
TEST FANK |
||
|
24 HOURS |
48 HOURS |
24 HOURS |
48 HOURS |
CONTROL GROUP |
0/10 |
0/10 |
0/10 |
0/10 |
TEST ARTICLE GROUP |
0/20 |
0/20 |
1/20 |
0/20 |
Note : Vehicle was peanut oil for both control and CA 2215 A (intermediate of CGA 276854) groups.
Table 5: Individual Challenge Skin Reactions, Vehicle Control Group
Driaze Scores
SEX/ANIMAL# |
VEHICLE FLANK |
TEST FLANK |
||||||
24 HOURS |
48 HOURS |
24 HOURS |
48 HOURS |
|||||
ERYTHEMA |
EDEMA |
ERYTHEMA |
EDEMA |
ERYTHEMA |
EDEMA |
ERYTHEMA |
EDEMA |
|
M/271 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
M/272 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
M/273 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
M/274 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
M/275 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
||||||||
F/286 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
F/287 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
F/288 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
F/289 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
F/290 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Note: vehicle was peanut oil
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- According to the Magnusson and Klingman Maximiszation grading, CA 2215 A (Intermediate of CGA 276854) is classified as aweak sensitizer, the lowest possible grade.
According to the test results, CA 2215 A (Intermediate of CGA 276854) is not required to be classified for skin sensitization according to Commission Directive 93/21/EEC, issued May 4, 1993. - Executive summary:
A dermal sensitization test was conducted with CA 2215 A (Intermediate of CGA 276854) batch P.608005) using the Maximization procedure. Two groups of guinea pigs (10 vehicle control, 20 test) were included. On day 0 , the test group animals were given a set of intradermal injections including (including 5.0% CA 2215 A (Intermediate of CGA 276854) in peanut oil for the test group). The epidermal induction application was made on day 8; the vehicle control animals were treated with the vehicle alone, and the test animals with 100% (undiluted) CA 2215 A (Intermediate of CGA 276854). The epidermal challenge application on day 21 consisted of a paired application of the vehicle alone and 0.5% CA 2215 A (Intermediate of CGA 276854) in peanut oil in both groups. Skin reactions on both the vehicle and test flanks were scord 24 and 48 hours after completion of the challenge application, according to the Draize scale.
Positive reactions on the test flanks were only observed in one female of the test group animals at the 24 hour examination. The sensitization rate for CA 2215 A (Intermediate of CGA 276854) was therefore 5%. There were no positive skin responses on the vehicle flanks and among the vehicle control group animals. There was no mortality, there were no remarkable clinical observations in any of the two groups. Body weights were not affected by treatment.
According to the test results, CA 2215 A (Intermediate of CGA 276854) is not required to be classified for skin sensitization according to Commission Directive 93/21/EEC, issued May 4, 1993.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.